Clinical CRO and real-world evidence services
The deciding factor
Excellent studies are shaped by thousands of correct decisions. Make the first one count with experienced, resourceful specialists in clinical development and real-world evidence.
Every promising medicine given the study it deserves
Start where your study is
By therapeutic area or stage of development
By therapeutic area
Deep expertise in three areas, chosen on purpose,
so the right people are on your study from day one.
By solution
From first dose through to post-approval evidence.
We deliver the full program or just the piece you need.
Experts behind every study
Senior clinicians, scientists, and epidemiologists who shape your study from the first conversation to the final report.
Meet our people
Kristy Nichols
Senior Vice President, Neuroscience
Laurence De Moerlooze
Senior Vice President, Infectious Diseases and Vaccines
Bronwyn Secourgeon
Associate Vice President, Cardiometabolic Diseases
Kaatje Bollaerts
Senior Vice President, Real-World Evidence
Manuel Castro Cabezas, MD, PhD
Expert Scientific Officer
Erik van Zandbergen
Senior Vice President, Operations
Check out our record
Decades of experience, and the record to prove it.
-
500+
Experts embedded
across 5 continents -
1,000+
Studies delivered,
with 1 in 3 real-world -
700k+
Participants enrolled, from single
sites to population-scale studies -
5,000+
Sites engaged across
75+ countries
Our therapeutic expertise
View our therapeutic scope
Neuroscience
Some of the hardest indications in medicine, run by people who have spent their careers in them. We know the endpoints, the raters and the sites that actually deliver.
Infectious diseases and vaccines
Respiratory and tropical infections, antimicrobial resistance, and global vaccine studies, run by teams on the ground where infectious diseases circulate. We read the epidemiology before we write the protocol.
Cardiometabolic diseases
Event-driven outcomes trials and the tough-to-recruit metabolic indications: obesity, diabetes, MASH, and lipid disorders. We keep the participants we recruit.
Your trusted partner from the clinic to the real world
Explore our solutions
Early phase clinical development
Confident first steps from first dose to proof of concept, with answers your next study can trust
Late phase clinical development
Phase IIb to Phase IV trials at scale, built to carry your program through approval and beyond
Real-world evidence studies
Regulatory-grade post-approval safety and effectiveness studies, led by RWE specialists who stay within reach
News and insights from our teams
Company news, fact sheets, and white papers from the people who design and run our studies.
News
P95 Julius Clinical Becomes AKEURA, a Specialist CRO in Clinical Development and Real-World Evidence
The new name completes the integration of P95 and Julius Clinical, bringing clinical development and real-world evidence together in one specialist company built around the experts behind every study.
Fact sheet
Tough gets us going: how we turn stalled studies around with a 30/60/90-day plan
Enrollment shortfalls, start-up delays, resource gaps, CRO transitions. Whatever’s putting your study at risk, our people have the experience and tenacity to fix it. Download the fact sheet to see our 30/60/90-Day Rescue Framework in action.
White paper
The next Ebola breakthrough starts before the outbreak: lessons from five past trials
From ring vaccination to community engagement, past Ebola trials show that speed comes from preparation. Our white paper turns five case studies into practical recommendations for running rigorous research in the toughest settings, starting with the 2026 Bundibugyo response.
Everything a study needs to succeed
A team of hands-on clinicians, scientists, and epidemiologists,
drawing on more than 25 years of experience.
They brought creative ideas to the project, were proactive throughout, and were led by an experienced team. We had a very positive experience and would definitely recommend them to anyone considering a top-notch CRO.
Pharmaceutical Company
Connect with an expert
Tell us what you need.
Your message goes to the team that handles your study.